🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

10 mg (50% DV)
✅ Within RDA (0.7× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 10mg UL 35mg
3 mg (150% DV)
✅ 2.3× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 3mg UL 100mg
250 mcg (4167% DV)
📊 104.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.25mg
Super HD Nootropic & CNS Support Blend:
Super HD ThermoSculpting Blend
253 mg
15.25 mg
📊 Market median: 3.0mg (58 products) 📚 2 studies — no high-quality reviews
This product: 15.25mg UL 20mg

Other Ingredients

capsule shell Microcrystalline Cellulose Stearic Acid Magnesium Stearate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement, during the first 2 days of use, begin by taking 1 capsule on an empty stomach 30 minutes before breakfast. An additional capsule may be taken 5-6 hours later during the mid-afternoon. Once tolerance has been assessed, an additional capsule may be added to the morning dose beginning no sooner than day 3. Under no circumstances should the initial morning dose of one capsule be exceeded during the first 2 days of use or the warnings on this bottle be ignored. DO NOT EXCEED 3 CAPSULES IN A 24 HOUR PERIOD. Drink plenty of water throughout the day to avoid dehydration.

Take up to 8 weeks before discontinuing for a minimum of 4 weeks.

⚠️ Warnings & Precautions

WARNING: Do not use if pregnant or nursing.

This product is not intended for use by those with a medical condition and only intended to be consumed by healthy adults 18 years of age or older.

Before using this product consult with your physician if you are using any prescription or over the counter medication or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication.

Discontinue use and consult your health care professional if you experience any adverse reaction to this product. Do not use if safety seal is broken or missing.

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

FEATURES: iFAS503(TM)

Additional Information

Woodbolt(TM) INTERNATIONAL

WEIGHT LOSS

HIGH-DEF FAT TARGETING & SCULPTING AGENT

ENERGY & FOCUS* APPETITE CONTROL* FAT METABOLISM*

Chrome Series 3RD GENERATION

GMP CERTIFIED

Store in a cool dry place.

PLEASE RECYCLE

v1.1

Product Details

UPC / SKU 6 32964 30243 4
DSLD Entry Date 2013-03-25
Product Type Other Combinations
Form Capsule
Brand Cellucor
DSLD ID 18926
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →